BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6585605)

  • 1. [Testicular damage caused by chemotherapy in acute lymphoblastic leukemia].
    Pasqualini T
    Medicina (B Aires); 1983; 43(5):579-86. PubMed ID: 6585605
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    Dhabhar BN; Malhotra H; Joseph R; Garde S; Bhasin S; Sheth A; Advani SH
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):306-10. PubMed ID: 8328644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular function after chemotherapy for acute lymphoblastic leukemia.
    Shalet SM; Lendon M; Morris Jones PH
    N Engl J Med; 1981 Aug; 305(9):520. PubMed ID: 6942224
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy and ovarian function. Retrospective analysis in 17 girls treated for malignant tumor or hematologic disease].
    Bakchine H; Brauner R; Thibaud E; Rappaport R; Flamant F; Griscelli C; Lemerle J; Schaison G; Schweisguth O; Zucker JM
    Arch Fr Pediatr; 1986 Oct; 43(8):611-6. PubMed ID: 3813783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
    An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease, splenectomy and secondary leukemia.
    Centurioni R; Brianzoni F; Leoni P; Danieli G
    Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
    [No Abstract]   [Full Text] [Related]  

  • 9. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM; Colonna P
    J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
    [No Abstract]   [Full Text] [Related]  

  • 10. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cancer polychemotherapy on gonadal function in Hodgkin's disease in adult men.
    Rao SV; Murugesan K; Vij U; Sarin R; Kapur BM
    Indian J Med Res; 1988 Jan; 87():37-41. PubMed ID: 3360481
    [No Abstract]   [Full Text] [Related]  

  • 12. Recently recognized complications of cancer chemotherapy.
    Arseneau JC; Canellos GP; DeVita VT; Sherins RJ
    Ann N Y Acad Sci; 1974; 230():481-8. PubMed ID: 4595953
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chromosome damage caused by antimitotics. General problems and clinical observations].
    Marinone G; Venturelli R
    Friuli Med; 1970; 25(2):85-119. PubMed ID: 5520696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myelodysplastic syndromes: a group of preleukemic disorders].
    Sizoo W; Hagenbeek A; Löwenberg B
    Ned Tijdschr Geneeskd; 1987 Sep; 131(38):1649-51. PubMed ID: 3670458
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
    Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA
    Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignancy complicating Hodgkin's disease.
    Tawil E; Mercier JP
    J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemoid reaction in acute lymphoblastic leukemia: a response to chemotherapy.
    Kaung DT
    J Iowa Med Soc; 1973 Mar; 63(3):114-7. PubMed ID: 4510700
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of spermatogenesis during chemotherapy for leukemia.
    Müller J; Skakkebaek NE; Hertz H
    Acta Paediatr Scand; 1985 Nov; 74(6):956-60. PubMed ID: 3867220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Matusewicz W; Drzewoski J; Robak T; Krykowski E
    Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.